Search

Search Constraints

You searched for: Author/Creator Asnafi, Vahid

Search Results

2. Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0. Issue 6 (20th December 2016)

3. Array‐CGH predicts prognosis in plasma cell post‐transplantation lymphoproliferative disorders. Issue 3 (1st November 2016)

4. Genetic characterization and therapeutic targeting of MYC‐rearranged T cell acute lymphoblastic leukaemia. (25th June 2018)

5. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study. (1st November 2014)

6. NAP1L1‐MLLT10 is a rare recurrent translocation that is associated with HOXA activation and poor treatment response in T‐cell acute lymphoblastic leukaemia. (12th October 2015)

7. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Issue 8 (17th November 2018)

8. Oncogenetic landscape of lymphomagenesis in coeliac disease. Issue 3 (12th February 2021)

9. Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high‐risk patients. (25th March 2014)

10. Quality assessment program for EuroFlow protocols: Summary results of four‐year (2010–2013) quality assurance rounds. (23rd October 2014)